ECONOMIC BURDEN AMONG CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH AND WITHOUT TYPE 2 DIABETES (T2D) IN A COMMERCIALLY INSURED/MEDICARE ADVANTAGE (MA) POPULATION IN THE UNITED STATES (US)

被引：0
|
作者：
Chung, H. [1 ]
Thomas, N. [1 ]
Willey, V [1 ]
Kong, S. X. [2 ]
Singh, R. [2 ]
Farej, R. [2 ]
Williamson, T. [2 ]
机构：
[1] HealthCore Inc, Wimlington, DE USA
[2] Bayer US LLC, Whippany, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE242
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [1] Comorbidity Burden Among Patients with CKD and Type 2 Diabetes in a US Commercially Insured/Medicare Advantage Population
    Chung, Haechung
    Thomas, Nicole M.
    Willey, Vincent
    Kong, Sheldon X.
    Singh, Rakesh
    Farej, Ryan
    Partridge, Jamie
    Elliott, Jay
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 276 - 276
  • [2] Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population
    Chung, Haechung
    Crowe, Christopher L.
    Kong, Sheldon X.
    Singh, Rakesh
    Farej, Ryan
    Elliott, Jay
    Williamson, Todd
    Willey, Vincent J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (01): : 80 - 89
  • [3] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [4] CHARACTERISTICS OF US COMMERCIALLY INSURED PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING TIRZEPATIDE
    Desai, K.
    Mody, R.
    Teng, C. C.
    Benneyworth, B.
    Reznor, G.
    Stockbower, G.
    Grabner, M.
    VALUE IN HEALTH, 2024, 27 (06) : S223 - S223
  • [5] Dosing Patterns of Tirzepatide (TZP) in Patients with Type 2 Diabetes (T2D) from a Commercially Insured US Population
    Mody, Reema
    Desai, Karishma
    Teng, Chia-Chen
    Reznor, Gally
    Stockbower, Grace
    Grabner, Michael
    Benneyworth, Brian D.
    DIABETES, 2024, 73
  • [6] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN COLOMBIA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mayorga, Mogollon W.
    Zuluaga, J. R.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S137 - S137
  • [7] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S74 - S74
  • [8] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S159 - S160
  • [9] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [10] Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)
    Harindhanavudhi, Tasma
    Freese, Rebecca L.
    Caramori, Luiza
    DIABETES, 2021, 70
12345